Xenon Pharmaceuticals Inc. (XENE) Declined -5.97% or -0.54 To Price $8.51 On Wednesday


Xenon Pharmaceuticals Inc. (XENE) declined -5.97% or -0.54 to $8.51. It is close to 119329 shares traded, which is 112.19% compare to the average total volume 106368. The market cap of XENE is $219.14 million. The year to date change is 29.51%. The 52 week price range is from $4.5 to $15.92. Price of XENE have changed -6.99% during last week. It have changed -2.48% over last month, 17.53% over last 3 months, -18.69% over last 6 months and 66.06% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for XENE is 9.12. It is 7.17% above current price. The 200-day Moving Averages for XENE is 9.68. It is 13.75% above current price. The 52-week High is 15.92. It is 87.07% from the current price. The 52-week Low is 4.5. It is -47.12% from current price.

There are some statistics of XENE. It is has market cap $219.14 million. The share outstanding is 25.75 million. The average volume is 106368. The percent of top 15 Institution holding is 80.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of XENE is -48.65%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of XENE is -37.96%.


Tags:

Share this post